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behavioral intentions. These ﬁndings have signiﬁcant
implications for consumer welfare and health policy.
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A STUDY ON SAVINGS AND HEALTH-RELATED
SAVING MOTIVE IN CHINESE RESIDENTS IN
HONG KONG
Zhang JX, Lau E
The Chinese University of Hong Kong, Shatin, Hong Kong
OBJECTIVES: The fairness in ﬁnancial distribution in
costs for healthcare is an important objective of a health-
care system proposed in World Health Report 2000 by
World Health Organization (WHO). This study examines
the health-related precautionary saving motive in Chinese
Hong Kong residents for the health policy action to gauge
on the private ﬁnancing for health care. METHODS: A
representative sample of 18,287 non-institutionalized
people above age of 18 and below age of 65 of years 
of old were surveyed for their health status, income, 
and savings. Saving rates were calculated as saving over
disposable income. We used a widely used method to 
estimate permanent income measure from cross-sectional
data developed by King and Dicks-Mireaux 1982, and
Starr-McCluer 1996. Multivariate regression analyses
were performed to investigate the association between
income and saving rates, and health and saving rates.
RESULTS: Saving rate was hump-shaped. It peaked in
age groups of 25–34 years of old, and declined steadily
toward retirement age. The number of children was a sig-
niﬁcant factor in determining saving rates in multivariate
regression adjusting for age, education, household 
composition, housing arrangements, and health status. As
permanent income rises, the saving rates rises. Measuring
health in terms of chronic conditions, risk behavior,
resource utilized in physician visits as well as number of
inpatient admissions, composite measure of chronic 
conditions, general health perception, saving rate was not
statically signiﬁcantly associated with health status.
CONCLUSION: Saving rate was distributed by the 
life-cycle events of child bearing. Health-related saving
motive was not found in Chinese residents in Hong Kong.
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ATTITUDES AS OUTCOMES: UNDERSTANDING
THE COMPLEXITY OF THE HEALTHCARE
CONSUMER
Annunziata K, Bolge SC, Eschmann B, McDonnell DD
Consumer Health Sciences, Princeton, NJ, USA
OBJECTIVES: Consumers are more involved with their
healthcare than in pre-internet, pre-DTC days. This leads
to consumer segments with different healthcare attitudes
and outcomes. Members of these groups, however, do not
report outcomes in isolation; they are ﬁltered through
their personality and position. This study illustrates the
diversity of healthcare consumers and discusses how 
outcomes research can beneﬁt by leveraging this varia-
tion. METHODS: An annual, self-reported study of U.S.
consumer attitudes and behaviors was ﬁelded in May
2001 and included 22,376 adult respondents. The sample
was stratiﬁed and weighted by key demographics. We
conducted a cluster analysis on 17 healthcare opinions,
designed to evaluate health-related compliance and
proactivity. RESULTS: Healthcare consumers segmented
into ﬁve clusters: Rockwellians (26%) visit and trust
doctors. They feel in control of and satisﬁed with their
healthcare. Independent Thinkers (22%) ruminate 
before they medicate and have self-reliant attitudes. Polly
Pharmas (21%) are healthcare information sponges.
What, Me Worries (19%), conversely, are indifferent 
to their healthcare. Angry Young Men (12%) feel worse
than they are, but do not act. Clusters differed by age,
gender, and education. These segments also had different
outcomes. For example, consistent with their negative
attitudes, Angry Young Men had the lowest mental
health, while content Rockwellians had the highest. Polly
Pharmas reported worse physical health and were most
likely to visit GPs (73%), while only half of What, Me
Worries (53%) did. Independent Thinkers were taking
fewer Rxs, though reporting an average number of con-
ditions. CONCLUSIONS: There is great variety among
healthcare consumers, correlating with diverse outcomes.
This illustrates the caveat for self-reported data, that con-
sumers’ subjective reports should be interpreted contex-
tually accounting for the type of healthcare consumer. 
We need to know who the “self” was that reported. 
Understanding—and measuring—this complexity should
be considered with adherence, resource use, and other
outcomes measures.
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Due to the lack of health knowledge in Taiwan, the
misuse of medication has resulted in severe harm to the
health of general public. Community university system is
one of the civil education systems in Taiwan, which 
is nation-wide and attended by general population in 
the surrounding communities. The community university
system would be an effective channel to disseminate the
pharmaceutical education to the general public. OBJEC-
TIVE: To establish the curriculum and teaching material,
and to recruit and train the lecturers for the pharmaceu-
tical education in community university system.
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METHODS: 1) Establishing the curriculum: The topics
of lectures which are important and of concern to the
general population were formulated through the survey
of pharmacists, pharmacy school faculty, and representa-
tives from consumer groups; 2) Developing teaching
material: After recognizing the topics, several groups of
pharmacists and pharmacy school faculty started writing
up the content of lectures; 3) Recruiting and training the
lecturers: Regional hospitals and pharmacist associations
were invited to recommend pharmacists for lecturers with
certain requisites. Then, four training sections were held
in four geographic regions in Taiwan; and 4) Coordina-
tion of the course program: Twenty community uni-
versities were participated in this project through the
coordination of the National Association for the Promo-
tion of Community Universities. RESULTS: Eighteen 
lectures (14 topics and 4 special lectures) were suggested
by the committee. Two sets of teaching material for 
lecturers and participants, respectively, were developed.
Four 16-hour training sections were completed in the
early December of 2002. One hundred ﬁfty selected out
of 190 pharmacists were ofﬁcially granted as the lectur-
ers. CONCLUSION: The curriculum will be implemented
in March 2003 in 20 community universities wide-spread
around the area of Taiwan.
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DEALIING WITH PRESCRIPTION DRUGS:
A NURSING HOME DILEMMA
Tennyson DH1,Williams GR2, Li T2
1Auburn University, Auburn, AL, USA; 2Bristol-Myers Squibb,
Princeton, NJ, USA
OBJECTIVES: Medicaid, and thus states, pay for the
majority of long term care delivered in the U.S. Nursing
homes discard large amounts of prescription drugs; esti-
mates are as high as 30% of the prescribed drugs in these
sites are discarded. The purpose of this preliminary study
is to analyze the dynamics of discarded drugs in nursing
homes. This is an important area of interest to policy-
makers and state ofﬁcials due to continuing budget 
constraints and increasing nursing home patient needs.
METHODS: This retrospective study reviews and 
analyzes prescription drug discard records and resident
demographic information for an entire year on two
nursing homes in a Southeastern state. One nursing home
is small, 50 beds, and the other is large, 213 beds. Simple
frequencies and cross-tabulations were run on the vari-
ables. RESULTS: There was an annual average of 12 dis-
carded drugs per nursing home bed with up to 69 drugs
discarded annually on individual nursing home residents.
Only about 5% of the discarded drugs were expired, with
the remaining discarded due to medicine discontinued on
that resident, or because the resident was discharged or
died. Approximately 25% of all drugs discarded during
the year of study were during the ﬁrst 6 months of the
resident being admitted to the nursing home, and 38% of
those were due to medication discontinuation. Signiﬁcant
differences exist in several variables, such as resident age
and medication type and reason for the medication being
discarded, between the two facilities. CONCLUSIONS:
This study categorizes the discarded drugs and shows 
the variety of drugs used in nursing homes. Formularies,
smaller initial dosages, and automated drug dispensers
are some possible solutions to help control the overall
increasing costs incurred, and, more speciﬁcally, to
control the large number of perfectly good prescription
drugs from being discarded.
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PUBLIC SUBSIDY OF PHARMACEUTICALS:
THE ECONOMIC CASE FOR AND AGAINST
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OBJECTIVE: The role of the state in providing health-
care is continually debated. In most developed economies,
public subsidy of pharmaceuticals distorts the market 
and has efﬁciency and equity considerations for govern-
ment, community and the pharmaceutical industry. 
This presentation discusses the economic case for and
against public intervention, and examines its impact.
METHODS: The argument for public subsidy states that
standard market mechanisms applied to pharmaceutical
markets do not necessarily produce the most efﬁcient or
equitable outcomes available. This is due to market 
failures associated with the use of prescription medicines.
Also, patients may undervalue social and personal health
beneﬁts obtained from medicines and may therefore
underconsume. Not all patients who are willing to pay
for medicines at the socially optimal price are able to 
do so. Publicly funded systems act to reduce prices by
altering the market dynamics. It is only when patients
overvalue beneﬁts of drugs that public subsidy leads to
overuse of prescription medicines. RESULTS: These
issues of market failure are addressed. It has been 
estimated that the Pharmaceutical Beneﬁts Scheme
subsidy contributes approximately $200 million annually
in improved efﬁciency to the Australian economy. It also
achieves equity improvements, as the highest PBS 
subsidies are received by lower income earners and the
aged. CONCLUSIONS: The pharmaceutical market in
Australia is relatively small in global terms. When gov-
ernment monopsony power is imposed on larger markets,
the potential decreased returns to pharmaceutical pro-
ducers may impact negatively on the incentives and ability
to innovate, placing future development of new medicines
at risk.
